These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 149393)

  • 1. Comparative immunochemical characterization of products of plasmin and leukocyte protease cleavage of human fibrinogen.
    Plow EF; Edgington TS
    Thromb Res; 1978 Apr; 12(4):653-65. PubMed ID: 149393
    [No Abstract]   [Full Text] [Related]  

  • 2. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.
    Plow EF; Edgington TS
    J Clin Invest; 1975 Jul; 56(1):30-8. PubMed ID: 237938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of leukocytic fibrinolytic enzymes from plasmin by the use of plasmatic proteolytic inhibitors.
    Hermann G; Miescher PA
    Int Arch Allergy Appl Immunol; 1965; 27(6):346-54. PubMed ID: 4220782
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular events responsible for modulation of neoantigenic expression: the cleavage-associated neoantigen of fibrinogen (blood coagulation-fibrinogen cleavage products-fibrinolysis-molecular conformation).
    Plow E; Edgington TS
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):208-12. PubMed ID: 4109598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFFECT OF PLASMIN ON FIBRINOGEN AND FIBRIN.
    GAJEWSKI J; ALEXANDER B
    Am J Physiol; 1964 Jan; 206():79-82. PubMed ID: 14111457
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunochemical demonstration of leucocyte proteases and inhibitors using fibrinagarelectrophoresis.
    Hermann G
    Prog Immunobiol Stand; 1970; 4():422-5. PubMed ID: 4249359
    [No Abstract]   [Full Text] [Related]  

  • 7. [APPLICATION OF IMMUNOCHEMICAL TECHNICS TO THE STUDY OF FIBRINOGEN AND ITS PRODUCTS OF DEGRADATION BY PLASMIN].
    SELIGMANN M; MARDER V
    Nouv Rev Fr Hematol; 1965; 5():345-54. PubMed ID: 14307707
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of fibrin degradation products in patients on ancrod therapy: comparison with fibrinogen derivatives produced by plasmin.
    Prentice CR; Edgar W; McNicol GP
    Br J Haematol; 1974 May; 27(1):77-87. PubMed ID: 4277400
    [No Abstract]   [Full Text] [Related]  

  • 9. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.
    Gramse M; Bingenheimer C; Schmidt W; Egbring R; Havemann K
    J Clin Invest; 1978 Apr; 61(4):1027-33. PubMed ID: 77863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of blood platelet function induced by neutral proteases from human leukocytes.
    Bykowska K; Kaczanowska J; Karpowicz M; Lopaciuk S; Kopeć M
    Thromb Res; 1985 Jun; 38(5):535-46. PubMed ID: 3892761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structure of fibrinogen in view of the properties and structure of proteolytic products of degradation by plasmin].
    Budzyński AZ
    Postepy Hig Med Dosw; 1969; 23(3):293-369. PubMed ID: 4240986
    [No Abstract]   [Full Text] [Related]  

  • 12. The generation of chemotactic activity for human leukocytes by the action of plasmin on human fibrinogen.
    McKenzie R; Pepper DS; Kay AB
    Thromb Res; 1975 Jan; 6(1):1-8. PubMed ID: 123093
    [No Abstract]   [Full Text] [Related]  

  • 13. A sensitive method for the determination of proteolytic activity in vitro by immunochemical quantitation of fibrinogen fragments.
    Ohlsson K
    Clin Chim Acta; 1969 Oct; 26(1):131-3. PubMed ID: 4243039
    [No Abstract]   [Full Text] [Related]  

  • 14. Distribution of carbohydrate among the polypeptide chains and plasmin digest products of human fibrinogen.
    Mills DA; Triantaphyllopoulos DC
    Arch Biochem Biophys; 1969 Dec; 135(1):28-35. PubMed ID: 4243528
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the proteolysis of fibrinogen and fibrin by Aspergillus ochraceus enzyme as compared to the action of plasmin.
    Teisseyre E; Latallo ZS; Kopeć M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):99-110. PubMed ID: 4134484
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the inhibition of proteolytic enzymes by serum. I. The mechanism of the inhibition of trypsin, plasmin, and chymotrypsin by serum using fibrin tagged with I131 as a substrate.
    SHULMAN NR
    J Exp Med; 1952 Jun; 95(6):571-91. PubMed ID: 14946321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on a proteolytic enzyme in human plasma. IX. Fibrinogen and fibrin as substrates for the proteolytic enzyme of plasma.
    RATNOFF OD
    J Clin Invest; 1953 Jun; 32(6):473-9. PubMed ID: 13052710
    [No Abstract]   [Full Text] [Related]  

  • 18. Properties of leucocytic protease.
    Ohlsson K
    Clin Chim Acta; 1971 May; 32(3):399-405. PubMed ID: 4255456
    [No Abstract]   [Full Text] [Related]  

  • 19. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW; Marder VJ
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence of plasmin proteolysis at the NH2-terminus of the b beta-chain of human fibrinogen.
    Koehn JA; Hurlet-Jensen A; Nossel HL; Canfield RE
    Anal Biochem; 1983 Sep; 133(2):502-10. PubMed ID: 6227262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.